| 注册
首页|期刊导航|中国现代中药|基于ITS2序列及其二级结构的市售前胡药材分子鉴定

基于ITS2序列及其二级结构的市售前胡药材分子鉴定

吴嘉仪 贺元 任广喜 姜丹 白贞芳 刘春生

中国现代中药2026,Vol.28Issue(5):881-887,7.
中国现代中药2026,Vol.28Issue(5):881-887,7.DOI:10.13313/j.issn.1673-4890.20251202003

基于ITS2序列及其二级结构的市售前胡药材分子鉴定

Molecular Identification of Commercial Peucedani Radix Products Based on ITS2 Sequence and Its Secondary Structure

吴嘉仪 1贺元 1任广喜 1姜丹 1白贞芳 1刘春生1

作者信息

  • 1. 北京中医药大学 中药学院,北京 102488
  • 折叠

摘要

Abstract

Objective:To identify the species of commercial Peucedani Radix products based on the internal transcribed spacer 2(ITS2)sequence and its secondary structure.Methods:A total of 103 samples labelled as Peucedani Radix were collected from 11 producing regions distributed across five herbal markets in Anhui,Hebei,Guangxi and other provinces.Genomic DNA was extracted,and the ITS2 region was amplified by polymerase chain reaction(PCR)and bidirectionally sequenced.MEGA 6.0 was used for sequence alignment,and the guanine+cytosine(GC)content and genetic distances were calculated.A neighbour-joining(NJ)phylogenetic tree was constructed.The ITS2 secondary structure was predicted using the ITS2 database.Species identification was then performed.Results:Authentic Peucedani Radix and its adulterants formed separate clades in the NJ tree.The ITS2 secondary structures differed in both the size and number of stem-loops within the helical regions.Based on the NJ tree and secondary structure analysis,the commercial samples originated from seven distinct species:Peucedanum praeruptorum,P.terebinthaceum,Ligusticum brachylobum Franch.,P.harry-smithii var.subglabrum,Angelica sinensis,Glehnia littoralis,and P.medicum.Conclusion:The DNA barcode based on ITS2 combined with its secondary structure signature can reliably distinguish authentic Peucedani Radix from its adulterants.

关键词

前胡/市售药材/内转录间隔区2/分子鉴定

Key words

Peucedani Radix/commercial Chinese medicinal materials/internal transcribed spacer 2(ITS2)/molecular identification

分类

医药卫生

引用本文复制引用

吴嘉仪,贺元,任广喜,姜丹,白贞芳,刘春生..基于ITS2序列及其二级结构的市售前胡药材分子鉴定[J].中国现代中药,2026,28(5):881-887,7.

基金项目

北京中医药大学企业横向课题(2019110031008880) (2019110031008880)

中国现代中药

1673-4890

访问量0
|
下载量0
段落导航相关论文